Study on the Clinical Effect of Percutaneous Vertebroplasty in the Treatment of Old Unstable Osteoporotic Spinal Fractures

Objective: To evaluate and analyze the actual efficacy of percutaneous vertebroplasty in the treatment of old unstable osteoporotic spinal fractures. Methods: From March 2023 to March 2024, 46 patients with old unstable osteoporotic spinal fractures in our hospital were included in this study. They were divided into the conventional group and the observation group based on treatment differences, with 23 patients in each group. The conventional group received conservative drug therapy, while the observation group underwent percutaneous vertebroplasty. The following indicators were compared and analyzed between the two groups: clinical treatment effect and improvement in physical function indicators. Results: The treatment efficiency of the observation group was 95.65% (22/23), while that of the conventional group was 69.57% (16/23). There was a significant difference between the groups, and the treatment effect of the observation group was significantly better (P < 0.05). After treatment, the scores of physical status, daily living ability, functional independence, and life obstacles in the observation group were (89.33 ± 4.08), (88.72 ± 4.08), (90.41 ± 2.89), (72.35 ± 3.22), respectively, while those in the conventional group were (68.54 ± 4.21), (67.42 ± 4.11), (73.48 ± 2.75), (72.35 ± 3.22). There was a significant difference between the groups, and the improvement in physical function indicators in the observation group was more pronounced (P < 0.05). Conclusion: For patients with old unstable osteoporotic spinal fractures, the basic value of percutaneous vertebroplasty is significant. It can not only improve clinical efficacy and safety but also promote the gradual recovery of patients’ physical function indicators. It is recommended for clinical reference and practical application.